Form 4: Agenus Inc. Director Jennifer Buell Receives Stock in Lieu of Cash as Part of Compensation Plan

Director Jennifer Buell received 516 shares of Agenus Inc. common stock as part of her compensation, in lieu of cash, according to a recent SEC filing.

Summary

• On February 7, 2025, Jennifer Buell, a director at Agenus Inc., acquired 516 shares of common stock.
• The shares were received as part of her salary, in lieu of cash, with the approval of the Agenus Inc. Compensation Committee.
• The price of the stock was $3.50 per share, which was the closing price of Agenus Inc. common stock on February 7, 2025.
• Following the transaction, Buell directly owns 14,692 shares of Agenus Inc. common stock.
• The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested upon issuance.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director accepting stock in lieu of cash suggests confidence in the company. However, it's a routine transaction and doesn't indicate a major shift in the company's prospects.

Positives

• The acceptance of stock in lieu of cash by a director demonstrates confidence in the company's future prospects.
• The shares are fully vested upon issuance, aligning the director's interests with those of the shareholders.

Management Comments

• A portion of Jennifer Buell's salary is being paid in stock, in lieu of cash, at her request and with the approval of the Agenus Inc. Compensation Committee.

Industry Context

Stock compensation is a common practice in the biotechnology industry, particularly for executive and director roles, to align management's interests with those of shareholders and incentivize long-term value creation. This practice helps conserve cash, which is crucial for research and development in this capital-intensive sector.

Comparison to Industry Standards

• Many biotech companies, such as Amgen, Gilead Sciences, and Biogen, utilize stock options and restricted stock units as part of their executive compensation packages.
• The percentage of compensation paid in stock varies, but it is generally higher for smaller, growth-stage companies compared to established, profitable firms.
• The vesting schedules and performance metrics associated with these stock grants also differ widely based on company-specific factors and industry benchmarks.

Stakeholder Impact

• Shareholders may view the director's acceptance of stock in lieu of cash as a positive sign, indicating alignment of interests.
• Employees may see this as a signal of the company's commitment to its leadership team.

Key Dates